HealthcareServices

Bipolar Disorder Therapeutics Market Forecast: What to Expect by 2029

November 24, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Bipolar Disorder Therapeutics Market Between 2025 And 2029?

The bipolar disorder therapeutics market has experienced significant expansion in recent years. This market is anticipated to expand from $7.44 billion in 2024 to $7.82 billion in 2025, achieving a compound annual growth rate (CAGR) of 5.1%. Historically, this growth can be ascribed to advancements in medical research and development, increased spending on healthcare, a rising occurrence of mental health disorders, and enhanced patient advocacy.

The bipolar disorder therapeutics market size is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach “$9.82 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 5.9%”. Factors contributing to this growth during the forecast period include the rising incidence of bipolar disorder, various government initiatives, the ongoing development of healthcare infrastructure, and the increasing embrace of a sedentary lifestyle. Key trends anticipated in this period encompass personalized treatment strategies, the integration of digital health technologies, the development of novel medications, a focus on preventive interventions, and advancements in neuroimaging and biomarkers.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6736&type=smp

Which Drivers Are Impacting The Bipolar Disorder Therapeutics Market?

The rise in healthcare expenditure is anticipated to advance the growth of the bipolar disorder therapeutics market moving forward. Healthcare expenditure encompasses all costs or investments made for medical treatment, preventative measures, public health programs, rehabilitation services, community health efforts, and health-related research. This surge in healthcare spending can be attributed to several elements, such as an aging populace, an increase in chronic conditions, and higher medication costs, collectively boosting the requirement for medical services and treatments. With greater awareness of mental health concerns, the identification of bipolar disorder increases, consequently driving a higher demand for therapeutic solutions. For instance, in November 2023, according to the Canadian Institute for Health Information, a Canada-based non-profit organization, overall health spending in Canada is projected to climb by 2.8% in 2023, following a modest increase of just 1.5% in 2022. Therefore, the expanding healthcare expenditure is a key factor stimulating the growth of the bipolar disorder therapeutics market.

How Is The Bipolar Disorder Therapeutics Market Classified Into Different Segments?

The bipolar disorder therapeuticsmarket covered in this report is segmented –

1) By Drug Class: Mood Stabilizers; Antipsychotic Drugs; Antidepressant Drugs; Other Drugs

2) By Mechanism: Selective Serotonin Reuptake Inhibitors; Serotonin-norepinephrine Reuptake Inhibitors; Tricyclic Antidepressants; Monoamine Oxidase Inhibitors; Benzodiazepines; Beta-Blockers; Other Mechanisms

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Subsegments:

1) By Mood Stabilizers: Lithium; Anticonvulsants; Calcium Channel Blockers

2) By Antipsychotic Drugs: Atypical Antipsychotics; Typical Antipsychotics

3) By Antidepressant Drugs: Selective Serotonin Reuptake Inhibitors (SSRIs); Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs); Tricyclic Antidepressants (TCAs)

4) By Other Drugs: Benzodiazepines; Adjunctive Therapies; Herbal Supplements

Which Ongoing Trends Are Expected To Shape The Bipolar Disorder Therapeutics Market Outlook?

Strategic partnerships are emerging as a significant development gaining traction in the bipolar disorder therapeutics market. Key companies operating within the bipolar disorder therapeutics sector are emphasizing collaborations to solidify their market presence. As an example, in April 2022, BioXcel Therapeutics, Inc., a US-based biopharmaceutical company, obtained approval for IGALMITM (dexmedetomidine), an FDA-approved sublingual film specifically indicated for the acute management of agitation associated with schizophrenia or bipolar I or II disorder in adults. This film is designed to dissolve in the mouth and is precisely formulated to target mild, moderate, or severe agitation across these patient groups. The drug is engineered to have a swift onset of action, allowing for effective control of agitation episodes.

Who Are The Core Companies Influencing The Bipolar Disorder Therapeutics Market Landscape?

Major companies operating in the bipolar disorder therapeutics market include AbbVie Inc., Pfizer Inc., Astellas Pharma Inc, AstraZeneca PLC, Bristol-Myers Squibb, GlaxoSmithKline PLC, Januaryssen Pharmaceuticals, Novartis AG, Otsuka Pharmaceutical Co. Ltd., Validus Pharmaceuticals, Eli Lilly and Company, Gedeon Richter PLC., Sumitomo Pharma Co. Ltd, H. Lundbeck A/S, Janssen Pharmaceuticals, Sanofi S.A., Lundbeck A/S, Allergan plc, Takeda Pharmaceutical Company Limited, Sunovion Pharmaceuticals Inc., Alkermes plc, Mylan N.V., Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Celon Pharma SA, NeuroRx Inc., IntraCellular Therapies Inc., Sumitomo Pharma Co. Ltd., Vanda Pharmaceuticals Inc., Sage Therapeutics Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/bipolar-disorder-therapeutics-global-market-report

What Are The Key Regional Factors Influencing The Bipolar Disorder Therapeutics Market Growth?

North America was the largest region in the bipolar disorder therapeutics market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the bipolar disorder therapeutics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Bipolar Disorder Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=6736&type=smp

Browse Through More Reports Similar to the Global Bipolar Disorder Therapeutics Market 2025, By The Business Research Company

Healthcare Personal Protective Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/healthcare-personal-protective-equipment-global-market-report

Healthcare Reimbursement Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/healthcare-reimbursement-global-market-report

Healthcare Service Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/healthcare-service-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795